title: Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.
abstract: Vascular endothelial growth factor (VEGF) demonstrating pro-angiogenic activity promote new blood vessel formation in psoriatic lesions. The aim of this study was to evaluate the serum concentrations of VEGF, its soluble receptors (sVEGF R1 and R2) and VEGF content in scales of patients with psoriasis. To analyze possible association with activity of the disease, serum and scales from plaques were collected from 59 patients with exacerbated chronic plaque-type psoriasis. Mean concentrations of VEGF and sVEGF R1 in sera of patients were respectively two and four times higher than in healthy controls. Serum VEGF and sVEGF R1, but not sVEGF R2 demonstrated significant correlation with psoriasis area and severity index (PASI). There was also significant correlation between VEGF levels in serum and scales. Serum sVEGF R1 concentration was significantly elevated even in patients with low psoriasis activity (PASI<10), whereas increase of serum VEGF became significant in patients with medium activity (PASI: 10-20). Levels of serum VEGF and sVEGF R1 were the highest in patients with PASI>20. We confirmed association of both serum and scales VEGF concentrations with degree of psoriasis activity and demonstrated predominant increase of sVEGF R1 vs. VEGF in serum of patients with low psoriasis activity.
authors.affiliation: Department of Dermatology and Venereology Medical University of Bialystok, 15-540 Białystok, ul. Żurawia 14, Poland. iflisiak@umwb.edu.pl
authors.forename: Iwona
authors.initials: I
authors.lastname: Flisiak
authors.forename: Przemysław
authors.initials: P
authors.lastname: Zaniewski
authors.forename: Magdalena
authors.initials: M
authors.lastname: Rogalska
authors.forename: Hanna
authors.initials: H
authors.lastname: Myśliwiec
authors.forename: Jerzy
authors.initials: J
authors.lastname: Jaroszewicz
authors.forename: Bożena
authors.initials: B
authors.lastname: Chodynicka
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000503:physiopathology*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood / Q000502:physiology*; D055815:Young Adult
chemical_list: D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor